The proto-oncogene c-myc has been implicated as a central switch in the onset or progression of many types of cancer. However, the underlying molecular mechanism(s) responsible for c-Myc-induced tumorigenesis remains elusive. Human cMyc is a 439-amino-acid protein that when bound to its partner, Max, can interact with DNA and function as a transcription factor (4) . Myc-Max heterodimerization, which occurs through the interaction of C-terminal basic helix-loop-helix and leucine zipper motifs, is required for virtually all wellknown c-Myc-associated phenotypes: cell proliferation, growth, transformation, and apoptosis (9, 15) . In addition to these well-established phenotypes, recent studies have demonstrated that c-Myc expression can cause gross chromosomal aberrations and gene amplifications (16, 35, 36) . The onset and progression of tumors depend upon the stepwise accumulation of somatic mutations in proto-oncogenes and tumor suppressor genes. Therefore, destabilizing genomic integrity may accelerate the accumulation of mutations required for the aggressive growth and malignant progression of tumors (6, 29, 34) . As such, the c-Myc-induced genomic instability phenotype may provide an informative paradigm for understanding oncogeneinduced tumor progression in general.
One mechanism crucial to the maintenance of genomic stability is that of the DNA damage-induced checkpoints (12, 24, 44, 56) . Cell cycle checkpoints ensure the proper execution of sequential events of the eukaryotic cell cycle; unprepared entry into either S phase or M phase can be fatal. As a cellular surveillance system for DNA damage, the DNA damage-induced checkpoint is a specific class of cell cycle checkpoints that ensure that cells containing damaged DNA do not proceed into S phase or into mitosis (1, 11, 32, 62) . Many biochemical components of the G 1 /S checkpoint have been identified, such as the tumor suppressor p53 and the cyclindependent kinase inhibitor (CKI) p21/Cip1 (cyclin-dependent kinase inhibitor protein 1) (22, 61) . When stabilized by a DNA damage signal, p53 is homotetramerized and acts as a transcription factor. Importantly, CKI p21/Cip1 links p53 and the DNA damage-induced inhibition of cell cycle progression (11, 13) . These roles of p53 and p21/Cip1 in the DNA damage response have been firmly established through recent studies using gene knockout approaches (5, 10, 57, 58) . Inhibition of cyclin/Cdk then leads to hypophosphorylation of the tumor suppressor retinoblastoma protein (Rb). The hypophosphory-lated form of Rb (pRb) actively sequesters the E2F-1 transcription factor, preventing transactivation of E2F-1 targets. Since E2F-1-mediated transactivation is essential for progression into S phase, Rb-mediated inhibition of E2F-1 activity causes cell cycle arrest at G 1 /S. The crucial involvement of Rb in the DNA damage-induced G 1 /S arrest was demonstrated in a study employing Rb Ϫ/Ϫ nullizygous mouse fibroblasts. Expression of c-Myc is highly regulated throughout the cell cycle (4) , and deregulation of c-Myc leads to the alteration of cell cycle regulation, such as a shortened G 1 and facilitation of G 1 /S progression (43) . Therefore, we hypothesized that c-Myc overexpression may also override or alter the scheduled cellular response (cell cycle arrest) to DNA damage at the G 1 /S boundary. In our experiments with nontransformed immortal HMEC lines and normal mortal HMECs, we demonstrated that a transient excess of c-Myc activity was sufficient to alter the G 1 /S checkpoint. For comparison, two independent controls were also used: an N-terminally truncated c-Myc (cMycS) (50) and a dominant negative p53 (p53DD) (47) . Based on these findings, we suggest a model in which c-Myc can lead to an elimination of a crucial safeguard mechanism for genomic stability in human mammary epithelial cells (HMECs).
MATERIALS AND METHODS
Cell culture. To study the effects of c-Myc overexpression in HMECs, both nontransformed immortal HMEC lines (184A1N4 and MCF10A) and normal mortal HMECs were used. The 184A1N4 clone (provided by M. Stampfer, Lawrence Berkeley National Laboratory and University of California, Berkeley, Calif.) was initially derived from an epithelial outgrowth of reduction mammoplasty tissue that was subjected to chemical immortalization but not to malignant transformation (51, 52) . The 184A1N4-Myc line was originally established via retroviral transfection of 184A1N4 cells with a murine c-myc construct under the control of a constitutively active Moloney mouse leukemia virus (MoMuLV) long terminal repeat (LTR) promoter (54) . Both 184A1N4 and 184A1N4-Myc were maintained in improved minimal essential medium (Life Technologies, Rockville, Md.) supplemented with 0.5% fetal calf serum, 10 ng of epidermal growth factor (EGF) per ml, 5 g of insulin per ml, and 0.5 g of hydrocortisone per ml. The wild-type genomic sequences of p53 genes in 184A1N4 and 184A1N4-Myc cells were confirmed by PCR sequencing of all exons at the Molecular Diagnostics Shared Resource of the Lombardi Cancer Center. MCF10A (obtained from the American Type Culture Collection, Manassas, Va.) was originally derived from a subcutaneous mastectomy, performed on a 36-year-old parous premenopausal woman; cells were immortalized spontaneously (49, 53) . MCF10A was maintained in a 1:1 mixture of Dulbecco's modified Eagle medium and nutrient mixture F-12 medium (Life Technologies) supplemented with 5% horse serum, 20 ng of EGF per ml, 10 g of insulin per ml, and 0.5 g of hydrocortisone per ml. Normal, finite-life-span HMECs (1001-8, CC-2551) at passage 8, originally derived from reduction mammoplasty tissues, were purchased from Clonetics-BioWhittaker, Inc. (Walkersville, Md.), and cells between passages 8 and 10 were used for experiments (roughly three population doublings per passage). Population doubling times (PDTs) for normal HMECs were roughly 18 to 24 h under in vitro culture conditions. Normal HMECs were maintained according to the supplier's instructions in mammary epithelial cell growth medium (CC-3152), supplemented with 52 g of bovine pituitary extract per ml, 10 ng of human EGF per ml, 5 g of insulin per ml, and 0.5 g of hydrocortisone per ml and were grown in 37°C incubators with low (0.1 to 0.2%) CO 2 settings.
Transgene constructs and retroviral infection. A full-length human c-myc cDNA construct, cloned in the pLXSN (LTR-gene X-simian virus 40-Neo) retroviral vector, was obtained from M. Stampfer and P. Yaswen (Lawrence Berkeley National Laboratory and University of California). In pLXSN, transgene expression and polyadenylation are facilitated by a Moloney murine sarcoma virus (MoMuSV) LTR promoter and a MoMuLV LTR polyadenylation signal (41) . To create a retroviral construct expressing c-MycS, c-myc cDNA with a 5Ј truncation was prepared through sequential recombinant DNA manipulations. Human c-myc cDNA has a unique recognition site for EcoRV between the first AUG (the second translation start codon) and the second AUG (see Fig.   2A ), and pBluescript II SK(ϩ/Ϫ) possesses a unique EcoRV site which is immediately behind the EcoRI site in the multiple cloning site (MCS) of the vector. Therefore, after the initial subcloning of human c-myc cDNA into the EcoRI site at the MCS of the cloning vector, EcoRV fragments containing the 5Ј-truncated form of the human c-myc cDNA (c-mycS) were isolated by digesting the initial construct with EcoRV and were then subcloned back into the HpaI site in the MCS of pLXSN retroviral vector by blunt-end ligation (see Fig. 2B ). A subclone with c-mycS positioned in the correct direction was selected, and the predicted deletion of the 5Ј region containing MB-I was confirmed by DNA sequencing. The pLXSN-p53DD construct was provided by M. Oren (Weizmann Institute of Science, Rehovot, Israel). All cloning junctions in each construct were confirmed by DNA sequencing. For the preparation of a high-titer retrovirus stock, PA317 retroviral packaging cells were transfected with each construct, and G418-resistant high-titer-producing clones were selected. To obtain stably transfected MCF10A pooled clones, cells were infected at a multiplicity of infection (MOI) of 5 in the presence of 8 g of Polybrene per ml twice, sequentially, in order to increase the viral copy number in the infected cells (41) . After a week of drug selection with 200 g of G418 per ml, at least 1,000 independent colonies were pooled. The clones were pooled in order to overcome any effect of clonal variation and to examine the average effects of overexpression of transgenes. The pBabepuro-MycER constructs (encoding a fusion protein between N-terminal full-length human c-Myc and a C-terminal engineered ligand-binding domain of a murine estrogen receptor; its inactive c-Myc conformation changes into an active c-Myc form when it binds to 4-hydroxy-tamoxifen ) (19, 31) were obtained from T. Littlewood (Imperial Cancer Research Fund, London, United Kingdom) and L. Z. Penn (University of Toronto, Toronto, Canada). MycER was subcloned into an LXSN vector in order to have all constructs in a single type of retroviral backbone, and the L-MycER-SN retrovirus was used to infect MCF10A for the isolation of single clones. For the transient expression of transgenes in normal HMECs, cells were infected at an MOI of 5 for 12 h in the presence of 8 g of Polybrene per ml. Cells were then grown for 24 or 48 h to allow transgene expression and harvested for experimentation.
Cell proliferation assay. On day 0, exponentially growing (ϳ70% confluence) cells were harvested and plated on flat-bottom, 96-well plates (Becton Dickinson Labware, Franklin Lakes, N.J.) at a density of 10 4 cells per well. After overnight attachment, the media were refreshed. For day 1 (24-h) samples, immediately after media were refreshed, cells were washed twice with phosphate-buffered saline (PBS) and stained for 15 min with 0.5% crystal violet solutions containing 25% methanol as a fixative. After staining, cells were washed three times with tap water. Next, plates were allowed to air dry. After the plates were dry, the stain was dissolved by adding 100 l of 0.1 M sodium citrate-50% ethanol per well. The amount of stain was then quantitated and analyzed on a Vmax kinetic microplate reader (Molecular Devices, Menlo Park, Calif.) at 570 nm with the SOFTmax program. After the first medium change on day 1, culture media were not further refreshed, in order to prevent any disturbance of the growing cells.
␥-Irradiation for inducing DNA damage. DNA damage was induced by ionizing radiation (IR) treatment, using a 137 Cs source ␥-irradiator (Mark-I irradiator; JL Shepherd, San Fernando, Calif.), at a rate of 3.6 Gy per min, until the specified absorbed dosage was reached. For irradiation of attached cells in culture dishes, cells were plated and irradiated on day 2. For irradiation of suspended cells in conical flasks, each sample was adjusted to the same cell density (ϳ3 ϫ 10 6 cells per 5-ml culture medium in a 15-ml conical tube). All experimental samples, either in dishes or in flasks, were kept rotating on the turntable inside the irradiator during the irradiation procedure.
Flow-cytometric analysis of the cell cycle. For flow-cytometric experiments to determine DNA content and the cell cycle profile, cells were plated at a density of 1 ϫ 10 6 to 3 ϫ 10 6 cells per T-75 flask. At various time points, cells were harvested and fixed with ice-cold 100% ethanol with vortexing at low speed; cells were then placed at Ϫ20°C for overnight. After fixation, cells were centrifuged and washed once with PBS containing 1% bovine serum albumin. For staining with DNA dye, cells were resuspended in 0.5 to 1 ml of propidium iodide (PI) solution containing RNase and incubated at 37°C for 30 min, followed by overnight incubation at 4°C. Cell cycle profiles were obtained with a FACScan flow cytometer (Becton Dickinson, San Jose, Calif.) and data were analyzed with ModFit software (Verity Software House, Inc.) for cell cycle analysis and ReproMan software (TruFacts Software Inc.) for region analysis of sub-G 1 fractions.
BrdU labeling and immunofluorescence for de novo DNA synthesis. DNA synthesis was monitored by measuring incorporation of the artificial thymidine nucleotide analog 5-bromo-2Ј-deoxyuridine (BrdU) (Sigma, St. Louis, Mo.) into newly synthesized DNA. After ␥-irradiation, cells were plated on glass coverslips that had been prewarmed in media in 12-well culture plates. Cells (5 ϫ 10 4 per well) were plated and allowed, for the first 24 h, to grow in complete medium without BrdU. Next, cells were refreshed with complete medium containing 10 M (3-g/ml) BrdU and incubated for an additional 6 or 24 h for BrdU incorporation. BrdU was added to the medium from a 10,000ϫ stock solution in distilled water. After BrdU incubation, cells were washed three times with PBS (10 min each time) and fixed in 4% paraformaldehyde-PBS for 20 min. Next, the fixed cells were permeabilized with 0.5% Triton X-100-PBS. After the partial denaturation of DNA with 2 N HCl, cells were incubated with a fluoresceinconjugated anti-BrdU mouse monoclonal antibody (Roche/Boehringer Mannheim, Indianapolis, Ind.), at a 1:2 dilution (50 g/ml) for 1 h in the dark. Cells were then washed with PBS three times and counterstained with DNA dyes (PI or DAPI [4Ј,6Ј-diamidino-2-phenylindole]) for 5 min. Finally, after several additional PBS washes, the cover slips were mounted on glass slides with Prolong mounting medium (Molecular Probes, Eugene, Oreg.) for fluorescence microscopy. Quantitative analysis of immunofluorescence data was carried out with Image-Pro Plus software (Media Cybernetics, Silver Spring, Md.).
Western blot analysis. Cell lysates were prepared in 2ϫ Laemmli sample buffer, containing 1% sodium dodecyl sulfate (SDS) and ␤-mercaptoethanol. After approximately 10 6 cells had been collected in 100 l of sample buffer, whole-cell lysates were boiled for 10 min, cleared by centrifugation at 4°C, and stored at Ϫ80°C until use. For SDS-polyacrylamide gel electrophoresis, 20 l of the cleared lysates was loaded into a well of the gel. Separated proteins were transferred to Immobilon-P polyvinylidene fluoride membranes (Millipore, Bedford, Mass.). After tank transfer, membranes were blocked for 1 h at room temperature in PBS-0.05% Tween 20 (PBS-T) containing 5% nonfat dried milk and then probed with primary antibody diluted in PBS-T overnight in a 4°C cold room. Antibodies and concentrations were as follows: for human c-Myc, 9E10, 2 g/ml (4851A; Pharmingen, San Diego, Calif.); for human p53, PAb1801, 2.5 g/ml (Ab-2; Oncogene Research Products, Boston, Mass.); pan-species p53 PAb 421, 10 g/ml (Ab-1; Oncogene Research Products); for p21/WAF1, EA10, 1 g/ml (Ab-1; Oncogene Research Products); for human Rb, 1 g/ml (14001A; Pharmingen); for cyclin A, H-432, 1 g/ml (sc-751; Santa Cruz Biotechnology, Santa Cruz, Calif.); for p14/ARF, 1 g/ml (AHZ0472; Biosource, Camarillo, Calif.); and for ␣-tubulin, DM1A, 1:1,000 dilution (Ab-2; NeoMarkers, Fremont, Calif.). Blots were then washed with PBS-T three times for 10 min. All blots were next incubated in horseradish peroxidase-conjugated secondary goat anti-mouse or anti-rabbit antibody (1:3,000 dilution; Bio-Rad) for 1 h at room temperature for chemiluminescent detection.
Hoechst staining for microscopic analysis of apoptosis. For the analysis of c-Myc-induced apoptosis with the MCF10A-MycER system, cells were starved of EGF for 6 days in the presence of ethanol (a vehicle control) or 1 M 4-OHT. After harvest, cells were resuspended in 50 l of PBS, and cell density was checked by phase-contrast microscopy. Next, the entire population of resuspended cells was added to 350 l of Hoechst staining solution consisting of 10 g of Hoechst 33258 (B-2883; Sigma) per ml, 1% NP-40, and 3.7% formaldehyde in PBS. Finally, the condensed nuclei of apoptotic cells were examined by fluorescent microscopy. (20, 39) . For MCF10A and later studies, we irradiated an actively growing, asynchronous population of cells in order to avoid complications resulting from repeated growth factor withdrawal and stimulation. According to the flow-cytometric profile, MCF10A cells exhibited an increase in G 0 /G 1 phase fraction (represented by 2N DNA content) and exhibited a significant reduction in S-phase fraction following IR with 4 to 12 Gy (data not shown). We next introduced a human c-myc cDNA construct into MCF10A cells by retroviral infection ( Fig. 2A and C) . In addition to c-myc, we also employed two independent controls, a construct encoding an N-terminally truncated c-Myc (cmycS) and p53DD (Fig. 2B ). c-MycS was previously known to be defective in transactivation of c-Myc targets (50) . However, a recent study reported that some targets were transactivated by c-MycS (25) . It served as an additional control for comparison, together with the empty retroviral vector (LXSN) control. p53DD, an N-terminally truncated, dominant negative (tetramerization domain only) form of murine p53 (2, 47) , served initially as a potential positive control ( Fig. 2B and D) . p53DD was chosen in case the loss of p53 function provides an abolished-checkpoint phenotype in HMECs, as previously established in other cell types. Elimination of the G 1 /S checkpoint in the p53DD-overexpressing MCF10A cells was confirmed in subsequent experiments, and it served as a working positive control to be compared with the effects of c-Myc overexpression. After MCF10A cells had been infected with the recombinant retroviruses, we pooled all G418-resistant colonies from each infection procedure, in order to prevent clonal variations. In MCF10A-Myc cells (MCF10A cells infected with human c-myc), the level of c-Myc expression was greater than that of the MCF10A-LXSN control (MCF10A cells infected with empty retroviral vector only) (Fig. 2C) . Since it is known that c-Myc downregulates its own expression through an autorepression mechanism (14) , a majority of this signal may be due to expression of the introduced exogenous c-myc. The constitutive overexpression of exogenous c-myc was even more evident following ␥-irradiation (see Fig. 4 ). We also infected the mouse embryonic fibroblast line NIH 3T3 with the same retroviruses and confirmed the specific expression of the exogenous human c-myc by retroviral infection (Fig. 2C) . As expected, cells infected with c-mycS showed only the expression of a 46-kDa protein, a truncated version of human c-Myc.
Expression of p53DD was also confirmed by Western analysis (Fig. 2D) . Importantly, the overexpression of murine p53DD led to the increase of endogenous human full-length p53 proteins. This observation verified that the murine p53DD proteins bind to endogenous human p53 proteins to stabilize them and to inhibit their function. Hetero-oligomer formation between the p53DD miniproteins and the full-length p53 proteins has been known to impair the scheduled degradation of endogenous p53 and to lengthen its half-life (47) . The level of p21/Cip1 proteins was also low in MCF10A-p53DD cells, further indicating that the increased amount of p53 proteins in these cells is not functional.
To confirm the proproliferation activity of c-Myc, we performed a 96-well-plate proliferation assay (Fig. 2E) . Although we plated exponentially growing (ϳ70% confluence) cells on day 0, it appeared that the initial PDT is much longer than the later PDT. Since we usually plated the exponentially growing cells on the day before experiments, the initial PDT was more relevant for most experiments. (Fig. 3A) . Interestingly, irradiated MCF10A cells did not show a prominent accumulation of cells at G 2 /M, suggesting an attenuated G 2 /M checkpoint in this HMEC line. However, it was not easy to interpret the changes because nonirradiated controls also changed their cell cycle profile after being replated in the culture flask. In terms of changes in S fraction, while c-Myc did not provide a dramatic effect on changes in S-phase fraction at 24 h post-IR, its effect was clear at 48 h post-IR, compared to those of LXSN and MycS. The effects of c-Myc overexpression could be clearly perceived when the higher S-phase fraction in nonirradiated MCF10A-Myc than in nonirradiated MCF10A-LXSN and MCF10A-MycS cells at 48 h post-IR was taken into account. Following IR, MCF10A-Myc cells exhibited a degree of reduction in S phase (to ϳ46% of nonirradiated control:
Overexpression of murine p53DD (ϳ19 kDa) in p53DD-infected MCF10A cells was clearly detected with an anti-pan-species p53 C-terminal monoclonal antibody, PAb421. The accompanying increase of endogenous full-length human p53 (53 kDa) suggests the efficient binding of p53DD to endogenous p53. The same blot was reprobed with anti-p21/WAF1 antibody to confirm the absence of p53 function in p53DD-infected cells. Equal loading was confirmed by staining the membrane blot with amido black (data not shown). (E) Proliferation of the infected MCF10A HMECs was measured using a 96-well-plate assay. The x axis represents incubation time after plating, and the y axis represents an arbitrary unit of optical density at 570 nm. After crystal violet staining of cells on the plates at each time point, stained total cell proteins were dissolved in the sodium citrate solutions, and the absorption at 570 nm was measured as readout for cell proliferation. Error bars show standard deviations from sextuplicate samples. While the flow-cytometric data provided valuable information on the global changes in cell cycle progression in irradiated cells, they did not necessarily provide evidence for entry into S phase following IR. Therefore, in order to obtain more direct evidence for the inappropriate entry into S phase, we performed a BrdU incorporation assay, measuring de novo DNA synthesis and representing all cells encountering S phase following IR. MCF10A cells were preincubated for 24 h following IR before the addition of BrdU, in order to provide sufficient time for preexisting S-phase cells to move from S phase to the next cell cycle phase. Next, the culture media were changed to BrdU-containing complete media, and cells were incubated for an additional 24 h for BrdU incorporation. In all four groups of sample populations, although a 24-h BrdU incubation was allowed, nonirradiated controls failed to exhibit 100% saturation of BrdU incorporation (Fig. 3B) (LXSN, 45.4%; c-Myc, 53.2%; c-MycS, 50.7%; and p53DD, 54.8%). In these results, MCF10A-Myc and MCF10A-p53DD cells had more entries into S phase per unit of time; a greater percentage of nonirradiated cells incorporated BrdU for 24 h. As expected, while the irradiated MCF10A-LXSN and MCF10A-MycS cells demonstrated a significant loss of BrdU labeling (LXSN, 4.9%, and MycS, 1.5%) (Fig. 3B) , both c-Myc-and p53DD-overexpressing cells exhibited a higher percentage of BrdU incorporation following IR (c-Myc, 29.2%, and p53DD, 46.8%) (Fig. 3B) . Therefore, the flow-cytometric analysis pro- One consideration for the interpretation of our BrdU incorporation data might be that BrdU could be additionally incorporated into the damaged chromosomes during DNA repair following IR, regardless of checkpoint control. However, it is very unlikely that only c-Myc-or p53DD-infected cells undergo a massive DNA repair following the same dosage of IR. Inappropriate hyperphosphorylation of Rb and reappearance of cyclin A following IR in c-Myc-overexpressing MCF10A cells. To gain initial insight into the underlying molecular basis of the altered G 1 /S checkpoint in c-Myc-overexpressing cells, we measured post-IR time course changes in the levels of some important cell cycle-related proteins. We started with c-Myc itself. Interestingly, the oncoprotein itself was significantly downregulated, as early as 18 h post-IR, in the irradiated LXSN-, c-MycS-, and p53DD-infected MCF10A cells (Fig. 4A) . However, the level of c-Myc stayed relatively high and was unaffected by IR treatment in MCF10A-Myc. Rb is a prominent target for Cdk2-cyclin E and Cdk2-cyclin A during scheduled G 1 /S progression, and we wanted to assess any post-IR changes in Rb phosphorylation status and Cdk2 holoenzyme status in each transfected cell population. Reprobing the same blot with an anti-Rb antibody demonstrated inappropriate hyperphosphorylation of Rb, following IR, selectively in c-Myc-and p53DD-infected cells. We irradiated exponentially growing, asynchronous cells, and various levels of phosphorylation in Rb were detected at the 0-h time point. In all sample groups, the majority of hyperphosphorylated Rb (ppRb) disappeared as early as 5 h post-IR. pRb dominated until 24 h post-IR in LXSN-and c-MycS-infected cells. In contrast, the irradiated c-Myc-and p53DD-infected cells showed a rapid reappearance of ppRb (slower-migrating bands) as early as 18 h post-IR. Although the effects of c-Myc on post-IR Rb phosphorylation appeared to be moderate and delayed with respect to the effects of p53DD, they were significant compared to those of LXSN and MycS controls. The strength of the ppRb signal of c-Myc at 48 h post-IR was comparable to that of p53DD at 24 h post-IR. Cyclin A is known to be a positive regulatory subunit for Cdk2 and abundant both in late-G 1 -and in S-phase cells; the levels of cyclins mainly determine the activities of Cdk holoenzymes. While the levels of cyclin A were dramatically suppressed in the irradiated LXSNand c-MycS-infected cells 18 h post-IR, irradiated MCF10A-Myc and MCF10A-p53DD cells exhibited reappearance of cyclin A 24 h post-IR. The amount of cyclin A at 48 h post-IR in irradiated MCF10A-Myc cells was comparable to that of cyclin A at 24 h post-IR in irradiated MCF10A-p53DD cells.
To test the p53-dependent molecular changes to IR, we performed a time course Western blot analysis of p53 and its downstream effector, p21/Cip1. As expected, the endogenous p53 protein was upregulated in MCF10A-LXSN, MCF10A-Myc, and MCF10A-MycS cells at 3 h post-IR (Fig. 4B) . Stabilized, but nonfunctional, endogenous, full-length p53 in MCF10A-p53DD was also apparent. Next, upregulation of p21/Cip1 appeared as early as 6 h post-IR following the upregulation of p53. Max, the c-Myc partner, is known to maintain a constant level throughout the cell cycle; it served as a loading control in the Western analysis. A transient excess of c-Myc activity was sufficient to induce the inappropriate entry into S phase and DNA synthesis following IR. In experiments with the permanently transfected MCF10A line, we pooled the G418-resistant colonies to provide an average phenotype without clonal variations. However, it was demonstrated in a fibroblast model that deregulated c-Myc activity could induce various genomic instabilities in a reasonably short period, 2 days (22) . Therefore, to rule out any hypothetical effects potentially resulting from secondary genetic alterations acquired during the G418 selection period, it was necessary to determine whether the transient excess of c-Myc activity was sufficient to alter the G 1 /S arrest following IR. To address this question, we established a regulatable c-Myc system with MCF10A by utilizing the MycER construct. MycER is a fusion protein consisting of full-length human c-Myc (at the N terminus) and the hormone-binding domain of the murine estrogen receptor (ER) (at the C terminus). Only in the presence of an ER-binding ligand, such as 4-OHT, does the C-terminal hormone-binding domain fail to interfere with the function of c-Myc in the N terminus, enabling the activation of c-Myc in a posttranslational manner. First, we confirmed the expression of MycER in MCF10A cells, at the expected size of ϳ110 kDa (Fig. 5A ). In addition, Western analysis demonstrated that 4-OHT-treatment downregulated the endogenous c-Myc, in comparison to mock treatment with ethyl alcohol (EtOH) (vehicle control). This is consistent with negative feedback regulation at the c-myc promoter by active Myc-Max transcription factors. For the verification of a functional MCF10A-MycER system, we measured c-Myc-induced apoptosis in the absence of growth factor; a Hoechst 33258 dye assay was used to identify apoptotic nuclei. c-Myc is well known to promote apoptosis, particularly in the absence of growth and survival factors. Therefore, we starved cells of EGF for up to 6 days in the presence of EtOH or 4-OHT (Fig. 5B) . After 4 days of this treatment, the morphological difference between EtOH-treated cells and 4-OHT-treated cells was identifiable. In contrast to the flattened cells obtained with EtOH treatment and EGF starvation, 4-OHT treatment with EGF starvation induced slender cells (Fig. 5B) amounts of floating bodies. Using Hoechst 33258 dye staining, we were also able to identify fragmented and condensed apoptotic nuclei selectively in 4-OHT-stimulated MCF10A-MycER cells (ϳ3% of roughly 400 nuclei observed in samples of 4-OHT-treated, EGF-starved cells) ( Fig. 5C and D) . These observations confirmed that c-Myc activity could be regulated by 4-OHT in the MCF10A-MycER system. To determine directly if a transient excess of c-Myc activity is sufficient to attenuate DNA damage-induced G 1 /S arrest, we performed a BrdU incorporation assay, following 0 or 12 Gy of IR, in the presence of 4-OHT or EtOH (Fig. 6 ). In the absence of IR, 4-OHT-treated MycER cells showed a higher BrdU incorporation (37.1% of total nuclei) than EtOH vehicletreated ones (33.6% of total nuclei). In irradiated MCF10A-MycER cells, only those stimulated with 4-OHT demonstrated a suppressed, but significant amount (28.2% of total nuclei) of BrdU-labeled nuclei, consistent with results with permanently transfected MCF10A cells. In addition, significant amounts of multimicronucleated nuclei displaying BrdU incorporation were selectively identified in ␥-irradiated cells (Fig. 6 ) (our unpublished data). These BrdU-labeled micronuclei had morphologies distinct from those of the condensed apoptotic nuclei in these experiments. Therefore, although further in-depth analyses are required, it is unlikely that the BrdU incorporation occurred directly as a part of apoptosis.
Transient overexpression of c-Myc induced inappropriate entry into S phase following IR in normal HMECs. Establishment of immortal cell lines from primary human cells may involve mutations in known and/or unknown genes, complicating interpretation of cell cycle control and DNA damage response studies. Therefore, it was necessary to investigate whether overexpression of c-Myc attenuates the DNA damage- , personal communication). However, we wanted a control for any kind of potential effects of retroviral infection on cell cycle progression, at least at the moment of infection, so that we could study changes in cell cycle progression of undisturbed, normal HMECs following IR. We also used the c-MycS retrovirus as an additional control for the effects of c-Myc, based on the failure of c-MycS to induce attenuation of G 1 /S arrest in MCF10A. We confirmed the expression of transgenes in normal HMECs, following transient infection (Fig. 7A) . At 48 h postinfection, levels of c-Myc and c-MycS were clearly elevated in c-Myc-and c-MycS-infected normal HMECs. c-Myc-infected HMECs demonstrated slight increases in levels of p53 and of p14/ARF, which are known transcriptional targets of Myc-Max transcription factors in some cell types (46) . The p53DD-infected normal HMECs consistently demonstrated an increased level of endogenous p53 proteins that are probably stabilized by murine p53DD. Consistent with data from MCF10A-p53DD cells (Fig. 2D) , p53DD-infected cells exhibited a decreased level of p21/Cip1 proteins. We first examined the response of normal HMECs to ␥-irradiation by phase-contrast microscopy (data not shown). In this experiment, transiently infected cells were irradiated with 0 or 12 Gy of IR, and then morphological changes were observed. Flattened cellular morphologies were apparent in noninfected and c-MycS-infected HMECs. However, following prolonged post-IR incubation, c-Myc-and p53DD-infected cells frequently demonstrated rounded or floating bodies. We next performed a BrdU incorporation assay, following 0 or 12 Gy of IR (Fig. 7B and C) . In this series of experiments, we used a 6-h BrdU pulse, in addition to a 24-h BrdU incubation, in order to avoid potential complications resulting from a prolonged BrdU incubation. All four nonirradiated groups of samples exhibited significant incorporation of BrdU after a 6-h BrdU pulse (Fig. 7B) 
DISCUSSION
According to previous studies, overexpression of c-myc induces aneuploidy, polyploidy, and gene amplifications in cultured fibroblasts (16, 35, 36) . Chromosome translocations, trisomy, and dicentric chromosomes in mouse mammary carcinoma cells derived from c-myc-transgenic mice have also been identified (33, 37, 59) . However, the underlying mechanism(s) for these dramatic effects of deregulated c-Myc on the destabilization of the cellular genome is largely unknown. As an approach to identify a possible mechanism(s) for this cMyc-induced genomic instability, we examined the effects of c-Myc overexpression on the DNA damage-induced cell cycle checkpoints in the present study. (Fig. 1) . In experiments with MCF10A, despite the absence of G 2 /M arrest, irradiated cells apparently arrested at the G 1 /S boundary and effects of c-Myc overexpression on the G 1 /S arrest were clearly demonstrated (Fig. 3) . Furthermore, we clearly demonstrated that a transient excess of c-Myc activity was sufficient to alter the DNA damage-induced G 1 /S arrest and induced the inappropriate entry into S phase (Fig. 6) . However, according to a previous study performed in an immortal 32D murine myeloid cell line (61a), c-Myc expression itself had no effects on the cell cycle arrest following IR. On the other hand, overexpression of c-Myc abolished another type of cell cycle checkpoint (previously known as a spindle assembly checkpoint) and accelerated the appearance of tetraploidy in 32D cells following nocodazole (a mitotic spindle poison) treatment. The effects of c-Myc expression on this spindle assembly checkpoint in 184A1N4 HMECs were also demonstrated in an independent study (30) . It has not yet been determined whether this c-Myc-mediated alteration of cellular response to a mitotic spindle poison is potentially linked, at the molecular level, to the altered DNA damage-induced G 1 /S checkpoint phenotype in c-Myc-overexpressing HMECs.
A caveat for studying cell cycle checkpoints with immortalized lines is that the checkpoint alteration phenotypes could be contributed by additional genetic mutations acquired during the immortalization process or during repeated passaging of the cell lines. In particular, it has been shown that in mouse embryonic fibroblasts (MEFs), the vast majority (reportedly ϳ80%) of rare, immortal fibroblasts were hypotetraploid and harbored mutant p53 alleles. Those that remain near-diploid frequently sustain biallelic loss of the p19/ARF locus (the mouse homolog of human p14/ARF) (48) . The importance of p19/ARF in constituting a fully functional G 1 /S checkpoint has been suggested in a previous study of p19/ARF Ϫ/Ϫ nullizygous MEFs which showed that loss of p19/ARF alters the DNA damage-induced G 1 /S arrest (27) . Furthermore, c-Myc has been proposed to upregulate p53 and ARF in some cell types (63) . Therefore, to resolve these controversial ideas, it was necessary to employ a primary cell system to study effects of c-Myc expression. Furthermore, the variable G 2 /M responses following IR in two immortal HMEC lines (184A1N4 and MCF10A) also prompted us to employ normal mortal HMECs in the checkpoint assay. We performed a series of experiments with normal HMECs and consistently observed that c-Myc significantly attenuated G 1 /S arrest following 12 Gy of IR ( Fig.  7 and 8 ). Flow-cytometric analyses also demonstrated a functional G 2 /M arrest following DNA damage in normal HMECs. Therefore, the absence of IR-induced G 2 /M arrest in MCF10A may reflect the immortalization history of this specific cell line. Interestingly, irradiated normal HMECs also demonstrated a relaxed G 1 /S arrest following IR (Fig. 8 ). According to a previous study on the DNA damage responses in normal HMECs (40) , HMECs demonstrated a lack of G 1 /S arrest following a limited dosage of 4 Gy of IR. We also identified an absence of G 1 /S arrest following 4 Gy of IR in our parental normal HMECs (data not shown). It is currently not known whether this relaxed G 1 /S arrest phenotype may be related to the fact that normal HMECs have an extended proliferative potential and the elimination of either p53 or p14/ARF is not necessary for their immortalization (28) .
In terms of effects of c-Myc expression in primary cells, we demonstrated that a transient overexpression of c-Myc in normal HMECs led to slightly elevated levels of p53 and p14/ARF proteins (Fig. 7A) . However, it did not dramatically induce either cell cycle arrest or apoptosis in normal HMECs (Fig. 8) . A transient activation of MycER also failed to induce G 2 /M arrest in the MCF10A system (data not shown). These results are in striking contrast with a previous report on the effects of c-Myc in normal human fibroblasts (NHFs) (17) . In that study, a transient excess of c-Myc activity in NHFs dramatically induced cell cycle arrest at G 2 phase within 48 h. Therefore, further investigations are required to elucidate a potential difference between the responses of these two cell types to deregulated c-Myc. Interestingly, a recent study also emphasized the importance of cellular background. NHFs failed to upregulate ARF following the introduction of a Ras oncogene, suggesting a difference between human fibroblasts and murine cells in responding to an activated oncogene (60) .
How does c-Myc override the p53-dependent pathway? Downstream targets for the c-Myc-induced checkpoint alteration. Since its discovery some 20 years ago, c-Myc has been one of the most paradoxical oncogenes. It is well known that c-Myc facilitates two very important but seemingly opposite processes in cells, proliferation and apoptosis. The c-Myc-induced checkpoint alteration phenotype is not exempt from this type of paradox. p53 and ARF, two recently identified transcriptional targets of c-Myc (46), make c-Myc's action on the cell cycle even more intriguing. Although a significant increase of p53 protein was not detected following c-Myc infection of MCF10A, an IR-induced upregulation of p53 and p21/Cip1 protein was confirmed both in LXSN-and in c-Myc-infected HMECs over the same time course (Fig. 4B) . According to VOL. 22, 2002 c-Myc ALTERS G 1 /S ARREST AFTER ␥-IRRADIATION 1831 on February 23, 2013 by PENN STATE UNIV http://mcb.asm.org/ several independent reports, c-Myc transrepresses p21, a universal Cdk inhibitor (7, 8, 42) . Since p21 is a critical downstream effector of p53-mediated G 1 /S arrest, it would be a plausible target for c-Myc-induced override of this G 1 /S checkpoint. Our results however demonstrate only a subtle decrease of p21/Cip1 proteins in c-Myc-infected cells, following its initial upregulation at 6 h post-IR (Fig. 4B) . Therefore, further molecular analyses following IR-induced DNA damage are needed to address the possible role of p21/Cip1 in the c-Mycinduced alteration of the G 1 /S checkpoint. Another candidate downstream target of c-Myc for override of the G 1 /S checkpoint could be Rb. Rb is a major downstream effector of the p53-p21-Rb pathway for DNA damage-induced G 1 /S arrest. According to previous studies, the absence of Rb in the Rb Ϫ/Ϫ nullizygous MEFs leads to an inappropriate entry into the S-phase following IR treatment (23) . The reappearance of ppRb in irradiated c-Myc-infected MCF10A cells suggests the involvement of Rb inactivation in c-Myc-induced G 1 /S checkpoint alteration. However, because cells phosphorylate Rb whenever they prepare and initiate a scheduled entry into S phase, it is not clear yet whether c-Myc directly targets Rb phosphorylation or whether this effect is simply a reflection of entry into S. Expression of cyclin A is likely to have returned coincident with c-Myc-or p53DD-infected cells progressing again into S phase following IR. Reportedly, c-Myc transactivates cyclin E, and this results in deregulated activation of Cdk2-cyclin E and in hyperphosphorylation of Rb (3, 21, 26, 45) . Any possible change of cyclin E levels following IR has not yet been determined. We employed c-MycS initially to probe a potential distinction between the transactivation and the transrepression mediated by c-Myc. However, a recent study suggested the potential of c-MycS in transactivating endogenous target genes in NHFs and in immortalized rat fibroblasts (25) . This report also demonstrated that c-MycS has undetectable activity as an inducer of S phase in quiescent human fibroblasts. Irradiated c-Myc-overexpressing HMECs develop micronuclei, sub-G 1 populations, and >4N populations. An unexpected, intriguing finding of the present G 1 /S study is an induction of micronuclei and a development of the sub-G 1 and the Ͼ4N populations in irradiated c-Myc-overexpressing HMECs. According to a previous study of c-Myc-overexpressing rat embryonic cells (REC:Myc) using a computerized video time-lapse method (18, 55) , these REC:Myc were susceptible to IR-induced apoptosis after 4 to 9.5 Gy of IR. Cell death occurred primarily by postmitotic apoptosis, following several divisions of the irradiated cells. These results suggest the possibility of an altered G 2 /M entry in these cells, because the irradiated c-Myc-overexpressing REC were allowed to undergo several mitotic divisions. That study also reported that 60% of the progeny of 4-Gy-irradiated REC:Myc either had micronuclei or were sisters of cells with micronuclei. The formation of micronuclei was correlated to apoptosis, as cells with micronuclei were more likely to undergo apoptosis during the generation in which the micronuclei were observed (18) . Additionally, a study by McKenna et al. (38) reported a minimal delay in G 2 /M of Myc-expressing fibroblasts following IR. These studies provide interesting clues to stimulate further, rigorous investigations of the effects of deregulated c-Myc on DNA damage-induced arrest at the G 2 /M boundary. Interestingly, irradiated c-Myc-infected normal HMECs developed sub-G 1 and Ͼ4N populations (Fig. 8) . These results suggest possible effects of c-Myc on uncoupling of cell cycle progression following DNA damage and on the sensitization of cells to DNA-damaging agents, a phenotype previously demonstrated in p53-and p21-deficient cells (5, 58) .
Based on the present study, we propose that c-Myc alters the DNA damage-induced G 1 /S checkpoint, a molecular safeguard mechanism for genomic stability. This effect of c-Myc may provide a mechanistic link between c-Myc-induced cell cycle alteration, genomic instability, and its role as a potent oncogene.
